Remote photo screening effective in detecting eye damage in premature babies

July 10, 2014 by Helen Jones
Remote photo screening effective in detecting eye damage in premature babies
Credit: National Eye Institute, National Institutes of Health

(Medical Xpress)—Remote examination of eye scans can be nearly as effective as traditional eye exams in detecting premature newborns with a potentially blinding eye disorder, according to findings from a new federally funded study conducted by investigators at the Johns Hopkins Children's Center and 12 other institutions.

The condition, known as of prematurity, affects about 15,000 U.S. a year and is marked by abnormal growth of blood vessels in the light-collecting portion of the eye, or the retina. This leads to retinal scarring, detachment and eventually loss of eyesight. Many infants outgrow the disorder within a few weeks of birth, but 10 percent have a form severe enough to require prompt treatment to stave off permanent damage and vision loss.

The results of the new study, published online June 26 in JAMA Ophthalmology, provide evidence that the remote evaluation approach, known as telemedicine, can correctly identify those in need of surgery—a finding that can help speed up diagnosis and treatment among born in underserved areas of the country and around the world without pediatric eye experts.

The study, which involved more than 1,250 born in 13 neonatal intensive care units, compared how accurately either method could identify babies with forms of the disease severe enough to require further exams and, eventually, surgery. All babies were evaluated by both a pediatric ophthalmologist and by two non-physician image readers located off site who analyzed photographs of the babies' eyes obtained via retinal scans. Infants whose initial on-site exam showed retinopathy of prematurity had follow-up exams at approximately 10-day intervals to monitor disease progression. Babies who showed unremitting eye damage underwent corrective surgery.

The video will load shortly

Overall, physician exam and remote image reading had similar accuracy in picking up severe forms of the disease. Remote image readers correctly identified 90 percent of patients diagnosed by expert ophthalmologists. When presented with images of infants with milder forms of the disease, the image readers accurately identified them as not severe 87 percent of the time. When investigators focused solely on results of the final exam, the accuracy of remote image readers increased to 98 percent, suggesting that detection greatly improves as the disease progresses.

"Our findings provide solid evidence that remote evaluation of newborns with eye disease is an effective and safe alternative to frequent physician exams in areas that lack access to such specialized services," says Michael X. Repka, M.D., a pediatric ophthalmologist at the Wilmer Eye Institute at Johns Hopkins and director of ophthalmology at the Johns Hopkins Children's Center.

The investigators, however, caution that despite its high accuracy, the remote screening approach is not perfect and that a small number of babies requiring treatment could be missed by remote evaluation.

"One missed case is one case too many," Repka says. "This approach was highly accurate in detecting severe retinopathy of prematurity but no screening system or exam for this condition is yet fool-proof so we need to design and implement safeguards that would render remote screening 100 percent accurate 100 percent of the time. This is our next step."

Explore further: Telemedicine catches blinding disease in premature babies

More information: The report, "Outcome Study of Cryotherapy for Retinopathy of Prematurity," is available online: www.nei.nih.gov/neitrials/static/study32.asp

Related Stories

Telemedicine catches blinding disease in premature babies

June 26, 2014
Telemedicine is an effective strategy to screen for the potentially blinding disease known as retinopathy of prematurity (ROP), according to a study funded by the National Eye Institute (NEI). The investigators say that the ...

Pre-term infants with severe retinopathy more likely to have non-visual disabilities

February 4, 2014
In a group of very low-birth-weight infants, severe retinopathy of prematurity was associated with nonvisual disabilities at age 5 years, according to a study in the February 5 issue of JAMA.

New report documents cardiopulmonary arrest in premature infant after cyclomydril eyedrops

April 3, 2014
Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American ...

Recommended for you

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

Drug shows promise against vision-robbing disease in seniors

June 21, 2017
An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Reproducing a retinal disease on a chip

June 15, 2017
Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are ...

New gene therapy for vision loss proven safe in humans

May 16, 2017
In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.